AMRN logo

AMRN
Amarin Corp - ADR

30,524
Mkt Cap
$300.71M
Volume
60,587.00
52W High
$20.90
52W Low
$7.52
PE Ratio
-7.68
AMRN Fundamentals
Price
$14.45
Prev Close
$14.67
Open
$14.51
50D MA
$15.03
Beta
1.03
Avg. Volume
88,526.55
EPS (Annual)
-$1.87
P/B
0.65
Rev/Employee
$2.68M
$7.15
Loading...
Loading...
News
all
press releases
Merck to Boost Oncology Pipeline With $6.7B Terns Buyout, Stock Up
MRK's $6.7B Terns buyout is set to add a promising leukemia drug candidate, boosting its oncology pipeline as it prepares for Keytruda's patent cliff.
Zacks·3d ago
News Placeholder
More News
News Placeholder
Amarin (NASDAQ:AMRN) Shares Pass Above 200-Day Moving Average - Should You Sell?
Amarin (NASDAQ:AMRN) Stock Price Passes Above 200-Day Moving Average - What's Next...
MarketBeat·13d ago
News Placeholder
Amarin (NASDAQ:AMRN) Stock Rating Upgraded by Zacks Research
Zacks Research raised Amarin from a "strong sell" rating to a "hold" rating in a report on Wednesday...
MarketBeat·23d ago
News Placeholder
AMRN Stock Soars 37.7% in a Year: Here's What You Need to Know
Amarin shares surge 37.7% in a year as restructuring, cost cuts and expanding Vazkepa partnerships for international growth fuel optimism.
Zacks·24d ago
News Placeholder
Amarin (NASDAQ:AMRN) Stock Rating Lowered by Wall Street Zen
Wall Street Zen cut shares of Amarin from a "buy" rating to a "hold" rating in a research note on Saturday...
MarketBeat·30d ago
News Placeholder
Amarin's Q4 Earnings Beat Estimates, Stock Down as Revenues Miss
AMRN swings to Q4 profit and beats estimates, but revenues decline 21% as Vascepa sales slide and shares fall 9% on the mixed results.
Zacks·1mo ago
News Placeholder
Amarin (NASDAQ:AMRN) Announces Earnings Results
Amarin (NASDAQ:AMRN - Get Free Report) announced its earnings results on Wednesday. The biopharmaceutical company reported $0.01 earnings per share (EPS) for the quarter, topping analysts' consensus...
MarketBeat·1mo ago
News Placeholder
Amarin Q4 Earnings Call Highlights
Amarin (NASDAQ:AMRN) executives told investors that 2025 marked a substantial achievement year as the company advanced a strategic pivot toward a more partnered international commercial model and...
MarketBeat·1mo ago
News Placeholder
Amarin Corp Earnings Report: Q4 Overview
read more...
Benzinga·1mo ago
News Placeholder
Amarin (AMRN) to Release Quarterly Earnings on Wednesday
Amarin (NASDAQ:AMRN) will be releasing its Q4 2025 earnings before the market opens on Wednesday, February 25. (View Earnings Report at...
MarketBeat·1mo ago
<
1
2
...
>

Latest AMRN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.